MDM2 Antibody

About the Target

MDM2 (Mouse doubleminute 2 homolog) is a key E3 ubiquitin ligase encoded by the MDM2 gene, primarily responsible for regulating the tumor suppressor p53 by promoting its ubiquitination and proteasomal degradation. MDM2 contains an N-terminal domain that binds the transactivation domain of p53, inhibiting its transcriptional activity, a central acidic domain involved in nuclear-cytoplasmic shuttling and protein-protein interactions, and a C-terminal RING finger domain that mediates E3 ubiquitin ligase activity by recruiting E2 ubiquitin-conjugating enzymes. Depending on the literature source, MDM2 may also be discussed as MDM2/HDM2.

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following MDM2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

MDM2 is commonly interpreted in the context of cancer research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm and nucleus across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• co-patterning with orthogonal markers and control conditions that clarify pathway state
• time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for MDM2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in MDM2 reflect biology rather than handling. When interpreting MDM2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep MDM2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.